Related Experiment Video
Updated: Aug 29, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Transforming growth factor-beta signaling is differentially inhibited by Smad2D450E and Smad3D407E
Miki Kondo1, Hiroyuki Suzuki, Kazuhiko Takehara
1Department of Biochemistry, The Cancer Institute of the Japanese Foundation for Cancer Research (JFCR), Toshima-ku, Tokyo 170-8455, Japan. mit-kato@md.tsukuba.ac.jp
Abstract:
A missense mutant of Smad2, Smad2D450E, that was not phosphorylated by transforming growth factor beta (TGF-beta) signaling, was identified in colorectal cancer. Previously, we constructed a mutant Smad3, Smad3D407E, which has an Asp to Glu mutation in the corresponding position of Smad2D450. Smad3D407E was not phosphorylated by the constitutively active form of the TGF-beta type I receptor, and inhibited the phosphorylation of co-expressed wild-type Smad2 and Smad3. In the present study, we examined the inhibitory effects of Smad2D450E on TGF-beta signaling and found that there are considerable differences between Smad2D450E and Smad3D407E. Smad2D450E suppressed the phosphorylation of Smad2, but did not affect the phosphorylation of Smad3, while Smad3D407E blocked the phosphorylation of both Smad2 and Smad3. Consistent with these results, Smad2D450E reduced hetero-oligomer formation of Smad2 with Smad4, but not of Smad3 with Smad4, while Smad3D407E reduced hetero-oligomer formation of both Smad2 and Smad3 with Smad4. However, Smad2D450E reduced the binding of Smad3 to a target DNA element as well as Smad2-binding, and Smad2D450E had inhibitory effects on the transcriptional activity of several targets, as Smad3D407E did. These results suggested that Smad2D450E might block the Smad3-mediated TGF-beta signaling in a hitherto unknown manner after the phosphorylation and hetero-oligomer formation, such as in the process of nuclear translocation or transcriptional regulation, which we could not identify previously by using Smad3D407E.
Insights
A novel Smad2 mutant (Smad2D450E) identified in colorectal cancer inhibits transforming growth factor beta (TGF-beta) signaling differently than a previously studied Smad3 mutant. Smad2D450E uniquely impacts Smad3-mediated signaling downstream of phosphorylation and hetero-oligomerization.
Area of Science:
- Molecular Biology
- Cell Signaling
- Cancer Research
Background:
- Transforming growth factor beta (TGF-beta) signaling is crucial in cellular processes and often dysregulated in cancer.
- Smad proteins are key mediators of TGF-beta signaling.
- A missense mutant of Smad2 (Smad2D450E), identified in colorectal cancer, lacks phosphorylation by TGF-beta signaling.
Purpose of the Study:
- To investigate the inhibitory effects of the Smad2D450E mutant on TGF-beta signaling.
- To compare the inhibitory mechanisms of Smad2D450E with a previously characterized Smad3 mutant (Smad3D407E).
Main Methods:
- Expression of Smad2D450E and Smad3D407E mutants.
- Assessment of Smad2 and Smad3 phosphorylation.
- Analysis of Smad protein hetero-oligomerization with Smad4.
- Evaluation of Smad protein binding to DNA elements.
- Measurement of transcriptional activity of TGF-beta target genes.
Main Results:
- Smad2D450E suppressed Smad2 phosphorylation but not Smad3 phosphorylation, unlike Smad3D407E which inhibited both.
- Smad2D450E reduced Smad2-Smad4 hetero-oligomerization, but not Smad3-Smad4, whereas Smad3D407E affected both.
- Smad2D450E inhibited Smad3 binding to DNA and transcriptional activity, suggesting a post-hetero-oligomerization inhibitory mechanism.
Conclusions:
- Smad2D450E and Smad3D407E exhibit distinct inhibitory mechanisms on TGF-beta signaling.
- Smad2D450E may inhibit Smad3-mediated TGF-beta signaling through a novel pathway affecting nuclear translocation or transcriptional regulation.
- These findings provide new insights into the complex regulation of TGF-beta signaling in colorectal cancer.
More Related Videos
11:38Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
11:06Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System
Published on: July 30, 2018
Related Concept Videos
TGF - β Signaling Pathway
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Amplifying Signals via Enzymatic Cascade
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Hedgehog Signaling Pathway